Literature DB >> 28661708

Pilot Data Supporting Omega-3 Fatty Acids Supplementation in Medicated Children with Attention-Deficit/Hyperactivity Disorder and Deficits in Emotional Self-Regulation.

Timothy E Wilens1,2, Nicholas W Carrellas1, Courtney Zulauf1, Amy M Yule1,2, Mai Uchida1,2, Andrea Spencer1,2, Joseph Biederman1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28661708      PMCID： PMC6913100          DOI： 10.1089/cap.2017.0080

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN： 1044-5463            Impact factor:   2.576


× No keyword cloud information.
  4 in total

1.  Omega-3 eicosapentaenoic acid in bipolar depression: report of a small open-label study.

Authors:  Yamima Osher; Yuly Bersudsky; R H Belmaker
Journal:  J Clin Psychiatry       Date:  2005-06       Impact factor: 4.384

2.  Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial.

Authors:  Janet Wozniak; Joseph Biederman; Eric Mick; James Waxmonsky; Liisa Hantsoo; Catherine Best; Joanne E Cluette-Brown; Michael Laposata
Journal:  Eur Neuropsychopharmacol       Date:  2007-01-26       Impact factor: 4.600

3.  Understanding deficient emotional self-regulation in adults with attention deficit hyperactivity disorder: a controlled study.

Authors:  Craig B H Surman; Joseph Biederman; Thomas Spencer; Carolyn A Miller; Katie M McDermott; Stephen V Faraone
Journal:  Atten Defic Hyperact Disord       Date:  2013-02-15

Review 4.  Emotion dysregulation in attention deficit hyperactivity disorder.

Authors:  Philip Shaw; Argyris Stringaris; Joel Nigg; Ellen Leibenluft
Journal:  Am J Psychiatry       Date:  2014-03       Impact factor: 18.112
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.